Log in

OTCMKTS:SHTDFSinopharm Stock Price, Forecast & News

$2.43
-0.06 (-2.53 %)
(As of 08/12/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.41
Now: $2.43
$2.43
50-Day Range
$2.34
MA: $2.50
$2.82
52-Week Range
$2.00
Now: $2.43
$3.72
Volume2,057 shs
Average Volume9,144 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products in the People's Republic of China. Its Pharmaceutical Distribution segment offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. This segment distributes medicines, medical devices, and pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. The company's Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2018, this segment had 5,183 retail pharmacies. Its Medical Devices segment distributes medical devices. Its Other Business segment engages in the production, sale, and financial leasing of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China.
Read More

Beat the Market (BTM) Rank

Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

0.52 out of 5 stars


Industry, Sector and Symbol

Industry Medical Distributors
Sub-IndustryN/A
Current SymbolOTCMKTS:SHTDF
CUSIPN/A
CIKN/A
Phone86 21 2305 2666

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees69,722
Next Earnings DateN/A
OptionableNot Optionable
$2.43
-0.06 (-2.53 %)
(As of 08/12/2020 04:00 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SHTDF News and Ratings via Email

Sign-up to receive the latest news and ratings for SHTDF and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Sinopharm (OTCMKTS:SHTDF) Frequently Asked Questions

How has Sinopharm's stock price been impacted by Coronavirus (COVID-19)?

Sinopharm's stock was trading at $2.43 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, SHTDF stock has decreased by 0.1% and is now trading at $2.4270.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Sinopharm?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sinopharm in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Sinopharm
.

Has Sinopharm been receiving favorable news coverage?

News coverage about SHTDF stock has trended extremely negative recently, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores nearest to five being the most favorable. Sinopharm earned a news sentiment score of -4.1 on InfoTrie's scale. They also gave headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the stock's share price in the next several days.
View the latest news about Sinopharm
.

Are investors shorting Sinopharm?

Sinopharm saw a decline in short interest in April. As of April 15th, there was short interest totaling 2,176,400 shares, a decline of 42.8% from the March 31st total of 3,804,700 shares. Based on an average daily volume of 4,900 shares, the short-interest ratio is currently 444.2 days.
View Sinopharm's Short Interest
.

Who are some of Sinopharm's key competitors?

Who are Sinopharm's key executives?

Sinopharm's management team includes the following people:
  • Mr. Zhiming Li, Chairman (Age 56)
  • Mr. Yong Liu, Pres & Exec. Director (Age 50)
  • Mr. Yijian Wu, Company Sec. (Age 49)
  • Mr. Wanyong Lian, VP (Age 48)
  • Mr. Dongjiu Li, VP (Age 54)

What is Sinopharm's stock symbol?

Sinopharm trades on the OTCMKTS under the ticker symbol "SHTDF."

How do I buy shares of Sinopharm?

Shares of SHTDF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Sinopharm's stock price today?

One share of SHTDF stock can currently be purchased for approximately $2.43.

What is Sinopharm's official website?

The official website for Sinopharm is ir.sinopharmgroup.com.cn.

How can I contact Sinopharm?

The company can be reached via phone at 86 21 2305 2666.

This page was last updated on 8/13/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.